KidneyCure

KidneyCure Ltd. is a biotechnology company developing disruptive regenerative cell-derived therapy, to treat advanced chronic kidney disease (ACKD) and Lupus Nephritis (LN) patients.
KidneyCure leadership and the unique technology landscape have the distinctive potential to improve patients’ health and quality of life and reduce the economic and social burden.